PF-AtlasClinical Trials › NCT00008775

Pressure Support Ventilation During CF Exacerbations

Pressure support ventilation · Not specified

Registry ID
NCT00008775
Phase
Not specified
Status
Suspended
Drug / intervention
Pressure support ventilation
Sponsor
National Center for Research Resources (NCRR)
Locations
1

About this trial

Chest physiotherapy is recognized as a mainstay of cystic fibrosis therapy, and is particularly important during treatment of pulmonary exacerbations. For some patients, especially those with moderate to severe compromise of lung function, this therapy may impose a high demand in the work of breathing and energy expenditure. The goal of this study is to evaluate the effectiveness of adding pressure support ventilation (PSV) during chest physiotherapy sessions in patients with cystic fibrosis with moderate to severe lung function compromise being treated for a pulmonary exacerbation.

View NCT00008775 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT00008775 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.